These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20372826)
21. Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells. Svetlikova D; Kabat P; Ohradanova A; Pastorek J; Betakova T Antiviral Res; 2010 Dec; 88(3):329-33. PubMed ID: 20969894 [TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of type I and type III interferons against porcine reproductive and respiratory syndrome virus (PRRSV). Luo R; Fang L; Jin H; Jiang Y; Wang D; Chen H; Xiao S Antiviral Res; 2011 Aug; 91(2):99-101. PubMed ID: 21569798 [TBL] [Abstract][Full Text] [Related]
23. Antiviral and antiproliferative effects of canine interferon-λ1. Ichihashi T; Asano A; Usui T; Takeuchi T; Watanabe Y; Yamano Y Vet Immunol Immunopathol; 2013 Nov; 156(1-2):141-6. PubMed ID: 24126210 [TBL] [Abstract][Full Text] [Related]
24. Human interferon-lambda3 is a potent member of the type III interferon family. Dellgren C; Gad HH; Hamming OJ; Melchjorsen J; Hartmann R Genes Immun; 2009 Mar; 10(2):125-31. PubMed ID: 18987645 [TBL] [Abstract][Full Text] [Related]
25. Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. Miknis ZJ; Magracheva E; Li W; Zdanov A; Kotenko SV; Wlodawer A J Mol Biol; 2010 Dec; 404(4):650-64. PubMed ID: 20934432 [TBL] [Abstract][Full Text] [Related]
26. Integrative genomic analysis of interleukin-36RN and its prognostic value in cancer. Lv Z; Fan J; Zhang X; Huang Q; Han J; Wu F; Hu G; Guo M; Jin Y Mol Med Rep; 2016 Feb; 13(2):1404-12. PubMed ID: 26676204 [TBL] [Abstract][Full Text] [Related]
27. Type III Interferons in Viral Infection and Antiviral Immunity. Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714 [TBL] [Abstract][Full Text] [Related]
28. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells. Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1. Li Y; Xie J; Xu X; Wang J; Ao F; Wan Y; Zhu Y Protein Cell; 2013 Feb; 4(2):130-41. PubMed ID: 23150165 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population. Jin G; Kang H; Chen X; Dai D Infect Genet Evol; 2014 Jan; 21():8-14. PubMed ID: 24144988 [TBL] [Abstract][Full Text] [Related]
32. Regulation of IFN-λ1 promoter activity (IFN-λ1/IL-29) in human airway epithelial cells. Siegel R; Eskdale J; Gallagher G J Immunol; 2011 Dec; 187(11):5636-44. PubMed ID: 22058416 [TBL] [Abstract][Full Text] [Related]
33. mRNA expression of IFN-λs in the gingival tissue of patients with chronic or aggressive periodontitis: A polymerase chain reaction study. Bilichodmath S; Nair SK; Bilichodmath R; Mangalekar SB J Periodontol; 2018 Jul; 89(7):867-874. PubMed ID: 29717481 [TBL] [Abstract][Full Text] [Related]
34. Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells. Liu D; Chang CH; Rossi EA; Cardillo TM; Goldenberg DM PLoS One; 2013; 8(5):e63940. PubMed ID: 23696859 [TBL] [Abstract][Full Text] [Related]
35. Novel type III interferons produce anti-tumor effects through multiple functions. Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856 [TBL] [Abstract][Full Text] [Related]
36. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Megjugorac NJ; Gallagher GE; Gallagher G Blood; 2010 May; 115(21):4185-90. PubMed ID: 20233967 [TBL] [Abstract][Full Text] [Related]
37. Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production. Xue M; Wang W; He H; Li L; Zhang X; Shi H; Liu P; Feng L J Virol; 2022 Dec; 96(24):e0138822. PubMed ID: 36448799 [TBL] [Abstract][Full Text] [Related]
38. Disruption of Type III Interferon (IFN) Genes Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571 [TBL] [Abstract][Full Text] [Related]
39. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes. Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983 [TBL] [Abstract][Full Text] [Related]
40. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]